We are a metagenomic epidemiology laboratory at the Proctor Foundation that takes innovative approaches to understand how the various human microbiomes (ocular, gut, and upper respiratory tract) respond to clinically relevant perturbations in randomized controlled trials.

Specifically, we seek to identify mechanisms by which mass drug distribution to preschool children in Sub-Saharan countries leads to an improvement in childhood mortality. Concurrently, we carefully track antibiotic resistance in these communities to better inform public health policies. (Photo: Improving childhood mortality in Niger)

In addition to our molecular epidemiology work, we focus on using genomic technologies to efficiently identify causes of ocular infections (e.g. uveitis, conjunctivitis, corneal ulcers, and scleritis) with the goal of improving patient care and preventing blindness. (Photo: Outdoor clinic in Ethiopia)

We are committed to nurturing a culture that is supportive and welcoming, building a community where experience from every background is valued, and committing to providing excellent patient care through quality research and discovery.